230 related articles for article (PubMed ID: 37349834)
1. Ogt-mediated O-GlcNAcylation inhibits astrocytes activation through modulating NF-κB signaling pathway.
Dong X; Shu L; Zhang J; Yang X; Cheng X; Zhao X; Qu W; Zhu Q; Shou Y; Peng G; Sun B; Yi W; Shu Q; Li X
J Neuroinflammation; 2023 Jun; 20(1):146. PubMed ID: 37349834
[TBL] [Abstract][Full Text] [Related]
2. OGT-mediated O-GlcNAcylation promotes NF-κB activation and inflammation in acute pancreatitis.
Zhang D; Cai Y; Chen M; Gao L; Shen Y; Huang Z
Inflamm Res; 2015 Dec; 64(12):943-52. PubMed ID: 26407569
[TBL] [Abstract][Full Text] [Related]
3. Augmented O-GlcNAcylation attenuates intermittent hypoxia-induced cardiac remodeling through the suppression of NFAT and NF-κB activities in mice.
Nakagawa T; Furukawa Y; Hayashi T; Nomura A; Yokoe S; Moriwaki K; Kato R; Ijiri Y; Yamaguchi T; Izumi Y; Yoshiyama M; Asahi M
Hypertens Res; 2019 Dec; 42(12):1858-1871. PubMed ID: 31409917
[TBL] [Abstract][Full Text] [Related]
4.
Zhang J; Wei K; Qu W; Wang M; Zhu Q; Dong X; Huang X; Yi W; Xu S; Li X
J Neurosci; 2023 Jun; 43(25):4559-4579. PubMed ID: 37225434
[TBL] [Abstract][Full Text] [Related]
5. Augmented O-GlcNAcylation exacerbates right ventricular dysfunction and remodeling via enhancement of hypertrophy, mitophagy, and fibrosis in mice exposed to long-term intermittent hypoxia.
Yokoe S; Hayashi T; Nakagawa T; Kato R; Ijiri Y; Yamaguchi T; Izumi Y; Yoshiyama M; Asahi M
Hypertens Res; 2023 Mar; 46(3):667-678. PubMed ID: 36376492
[TBL] [Abstract][Full Text] [Related]
6. Dexmedetomidine Inhibits NF-κB-Transcriptional Activity in Neurons Undergoing Ischemia-Reperfusion by Regulating O-GlcNAcylation of SNW1.
She C; Zhu J; Liu A; Xu Y; Jiang Z; Peng Y
J Neuropathol Exp Neurol; 2022 Sep; 81(10):836-849. PubMed ID: 35818332
[TBL] [Abstract][Full Text] [Related]
7. Glucosamine improves cardiac function following trauma-hemorrhage by increased protein O-GlcNAcylation and attenuation of NF-{kappa}B signaling.
Zou L; Yang S; Champattanachai V; Hu S; Chaudry IH; Marchase RB; Chatham JC
Am J Physiol Heart Circ Physiol; 2009 Feb; 296(2):H515-23. PubMed ID: 19098112
[TBL] [Abstract][Full Text] [Related]
8. Chitosan oligosaccharides block LPS-induced O-GlcNAcylation of NF-κB and endothelial inflammatory response.
Li Y; Liu H; Xu QS; Du YG; Xu J
Carbohydr Polym; 2014 Jan; 99():568-78. PubMed ID: 24274545
[TBL] [Abstract][Full Text] [Related]
9. O-GlcNAcylation of NF-κB Promotes Lung Metastasis of Cervical Cancer Cells via Upregulation of CXCR4 Expression.
Ali A; Kim SH; Kim MJ; Choi MY; Kang SS; Cho GJ; Kim YS; Choi JY; Choi WS
Mol Cells; 2017 Jul; 40(7):476-484. PubMed ID: 28681591
[TBL] [Abstract][Full Text] [Related]
10. Hyper-
Ma Z; Chalkley RJ; Vosseller K
J Biol Chem; 2017 Jun; 292(22):9150-9163. PubMed ID: 28416608
[No Abstract] [Full Text] [Related]
11. Elevated O-GlcNAcylation promotes colonic inflammation and tumorigenesis by modulating NF-κB signaling.
Yang YR; Kim DH; Seo YK; Park D; Jang HJ; Choi SY; Lee YH; Lee GH; Nakajima K; Taniguchi N; Kim JM; Choi EJ; Moon HY; Kim IS; Choi JH; Lee H; Ryu SH; Cocco L; Suh PG
Oncotarget; 2015 May; 6(14):12529-42. PubMed ID: 25915426
[TBL] [Abstract][Full Text] [Related]
12. Single cell and bulk RNA expression analyses identify enhanced hexosamine biosynthetic pathway and O-GlcNAcylation in acute myeloid leukemia blasts and stem cells.
Schauner R; Cress J; Hong C; Wald D; Ramakrishnan P
Front Immunol; 2024; 15():1327405. PubMed ID: 38601153
[TBL] [Abstract][Full Text] [Related]
13. Hyper-O-GlcNAcylation is anti-apoptotic and maintains constitutive NF-κB activity in pancreatic cancer cells.
Ma Z; Vocadlo DJ; Vosseller K
J Biol Chem; 2013 May; 288(21):15121-30. PubMed ID: 23592772
[TBL] [Abstract][Full Text] [Related]
14. Augmented TME
Moriwaki K; Asahi M
Mol Cancer Res; 2017 Sep; 15(9):1287-1298. PubMed ID: 28536142
[No Abstract] [Full Text] [Related]
15. O-GlcNAcylation and p50/p105 binding of c-Rel are dynamically regulated by LPS and glucosamine in BV2 microglia cells.
Hwang SY; Hwang JS; Kim SY; Han IO
Br J Pharmacol; 2013 Aug; 169(7):1551-60. PubMed ID: 23646894
[TBL] [Abstract][Full Text] [Related]
16. mTOR/MYC Axis Regulates O-GlcNAc Transferase Expression and O-GlcNAcylation in Breast Cancer.
Sodi VL; Khaku S; Krutilina R; Schwab LP; Vocadlo DJ; Seagroves TN; Reginato MJ
Mol Cancer Res; 2015 May; 13(5):923-33. PubMed ID: 25636967
[TBL] [Abstract][Full Text] [Related]
17. OGT upregulates myogenic IL-6 by mediating O-GlcNAcylation of p65 in mouse skeletal muscle under cold exposure.
Hu Y; Liu Y; Yang Y; Lv H; Lian S; Xu B; Li S
J Cell Physiol; 2022 Feb; 237(2):1341-1352. PubMed ID: 34668190
[TBL] [Abstract][Full Text] [Related]
18. Protein
Dong H; Liu Z; Wen H
Front Immunol; 2022; 13():805018. PubMed ID: 35185892
[TBL] [Abstract][Full Text] [Related]
19. Hexosamine Biosynthetic Pathway-Derived O-GlcNAcylation Is Critical for RANKL-Mediated Osteoclast Differentiation.
Kim MJ; Kim HS; Lee S; Min KY; Choi WS; You JS
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445596
[TBL] [Abstract][Full Text] [Related]
20. IDH2, a novel target of OGT, facilitates glucose uptake and cellular bioenergy production via NF-κB signaling to promote colorectal cancer progression.
He X; Wu N; Li R; Zhang H; Zhao Y; Nie Y; Wu J
Cell Oncol (Dordr); 2023 Feb; 46(1):145-164. PubMed ID: 36401762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
